Last reviewed · How we verify

Cholecalciferol Pill — Competitive Intelligence Brief

Cholecalciferol Pill (Cholecalciferol Pill) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D supplement. Area: Nutritional/Metabolic.

marketed Vitamin D supplement Vitamin D receptor (VDR) Nutritional/Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Cholecalciferol Pill (Cholecalciferol Pill) — Hospital Infantil de Mexico Federico Gomez. Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and supports bone mineralization.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Cholecalciferol Pill TARGET Cholecalciferol Pill Hospital Infantil de Mexico Federico Gomez marketed Vitamin D supplement Vitamin D receptor (VDR)
Cholecalciferol 12 000 UI Cholecalciferol 12 000 UI Assistance Publique - Hôpitaux de Paris marketed Vitamin D supplement Vitamin D receptor (VDR)
Ergocalciferol (Vitamin D) Ergocalciferol (Vitamin D) Barts & The London NHS Trust marketed Vitamin D supplement Vitamin D receptor (VDR)
Traditional Vitamin D Therapy Traditional Vitamin D Therapy Amgen marketed Vitamin D supplement Vitamin D receptor (VDR)
Cholecalciferol 100 000 UI Cholecalciferol 100 000 UI University Hospital, Tours marketed Vitamin D supplement Vitamin D receptor (VDR)
ergocalciferol (vitamin D2) ergocalciferol (vitamin D2) Atlanta VA Medical Center marketed Vitamin D supplement Vitamin D receptor (VDR)
Ergocalciferol 50000 UNT Ergocalciferol 50000 UNT University of Alabama at Birmingham marketed Vitamin D supplement Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D supplement class)

  1. Hospices Civils de Lyon · 2 drugs in this class
  2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  3. Atlanta VA Medical Center · 1 drug in this class
  4. Barts & The London NHS Trust · 1 drug in this class
  5. Centre of Postgraduate Medical Education · 1 drug in this class
  6. Hospital Infantil de Mexico Federico Gomez · 1 drug in this class
  7. Post Graduate Institute of Medical Education and Research, Chandigarh · 1 drug in this class
  8. University Hospital, Tours · 1 drug in this class
  9. University of Alabama at Birmingham · 1 drug in this class
  10. Amgen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cholecalciferol Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/cholecalciferol-pill. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: